TAIPEI, Taiwan–(BUSINESS WIRE)–PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023.
A link to the live audio webcast of the presentation will be available on the News page of the PharmaEssentia USA website at us.pharmaessentia.com. An audio replay will be available for 30 days following the presentation.
About PharmaEssentia
PharmaEssentia (TPEx: 6446), headquartered in Taipei, Taiwan, is a global and rapidly growing biopharmaceutical innovator. Leveraging deep expertise and proven scientific principles, PharmaEssentia aims to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one approved product and a diversifying pipeline. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today PharmaEssentia is expanding its global presence with operations in the U.S., Japan, China, and Korea, along with a world-class biologics production facility in Taichung, Taiwan.
Contacts
Rachel Lipsitz, rachel_lipsitz@pharmaessentia.com
Key takeaways:Kimi Antonelli took pole position at the 2026 United States Grand Prix in Austin,…
Key takeaways:Delhi is under heavy to very heavy rain, causing waterlogging and traffic jams.Today's AQI…
Key takeaways:Lone'er Kavanagh defeated Ramazan Temirov by first-round TKO at UFC 333, a result UFC.com…
Key takeaways:Petr Yan defeated Merab Dvalishvili in their trilogy bout at UFC 333 and retained…
Key takeaways:Red Bull New York host Inter Miami CF in a 2026 MLS season match…
Key takeaways:Alexander Volkov headlines UFC 333 against Rizvan Kuniev, with coverage spanning live blogs, previews,…